StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by cybermanon Aug 28, 2020 9:29am

194 Views

Post# 31468849

RE:Hey can you all tell me if this is true?

at 5:1 it would still be a penny stock.

AngelMan92 wrote: I heard from a friend that the company is going to undergo a 5 to 1 reverse split to stay within TSX range and to get interest from investors who don't do penny stocks. Is this true? And if so can you pass a link as SEDAR doesn't show anything new.

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December